91 results
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
27 Feb 24
Results of Operations and Financial Condition
4:05pm
on an adjusted earnings per share basis for full year 2024, and has the financial flexibility to continue to invest in R&D and technology innovations
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
16 Jan 24
Results of Operations and Financial Condition
9:00am
in R&D with ongoing cost controls in SG&A. Adjusted EPS* $(0.33) - $(0.28) Adjusted EPS is expected to reach positive adjusted profitability
8-K
EX-99.1
4smstzhv
11 Jan 22
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
j102hypboahu9jwnfx
2 Nov 21
Continues Strong Execution of Strategic Growth & Transformation Plans
8:40am
8-K
EX-99.1
eya8lmww
3 Aug 21
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
7:05am
8-K
EX-99.1
dz3cc
13 Aug 20
Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results
4:15pm